JPH0236236B2 - - Google Patents
Info
- Publication number
- JPH0236236B2 JPH0236236B2 JP55030465A JP3046580A JPH0236236B2 JP H0236236 B2 JPH0236236 B2 JP H0236236B2 JP 55030465 A JP55030465 A JP 55030465A JP 3046580 A JP3046580 A JP 3046580A JP H0236236 B2 JPH0236236 B2 JP H0236236B2
- Authority
- JP
- Japan
- Prior art keywords
- polysaccharide
- capsular polysaccharide
- polysaccharides
- column
- hydrolyzate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000004676 glycans Chemical class 0.000 claims description 80
- 229920001282 polysaccharide Polymers 0.000 claims description 80
- 239000005017 polysaccharide Substances 0.000 claims description 80
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 24
- 238000004108 freeze drying Methods 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 15
- 239000004471 Glycine Substances 0.000 claims description 13
- 108010088751 Albumins Proteins 0.000 claims description 7
- 102000009027 Albumins Human genes 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 6
- 235000004279 alanine Nutrition 0.000 claims description 6
- 235000001014 amino acid Nutrition 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 6
- 235000018102 proteins Nutrition 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 238000000855 fermentation Methods 0.000 claims description 4
- 230000004151 fermentation Effects 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 239000005018 casein Substances 0.000 claims description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 3
- 235000021240 caseins Nutrition 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 108010076119 Caseins Proteins 0.000 claims description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
- 239000004472 Lysine Substances 0.000 claims description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 2
- 239000001888 Peptone Substances 0.000 claims description 2
- 108010080698 Peptones Proteins 0.000 claims description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 2
- 235000019319 peptone Nutrition 0.000 claims description 2
- 239000004474 valine Substances 0.000 claims description 2
- 230000001580 bacterial effect Effects 0.000 claims 2
- 230000000087 stabilizing effect Effects 0.000 claims 2
- 238000010828 elution Methods 0.000 description 22
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 12
- 239000005695 Ammonium acetate Substances 0.000 description 12
- 229940043376 ammonium acetate Drugs 0.000 description 12
- 235000019257 ammonium acetate Nutrition 0.000 description 12
- 239000003381 stabilizer Substances 0.000 description 9
- 230000015556 catabolic process Effects 0.000 description 6
- 238000006731 degradation reaction Methods 0.000 description 6
- 229960005486 vaccine Drugs 0.000 description 6
- 239000011800 void material Substances 0.000 description 6
- 229920002684 Sepharose Polymers 0.000 description 5
- 229960003767 alanine Drugs 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000004224 protection Effects 0.000 description 5
- 230000001681 protective effect Effects 0.000 description 5
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical compound CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 4
- 229920002307 Dextran Polymers 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 108010009736 Protein Hydrolysates Proteins 0.000 description 3
- 102000007562 Serum Albumin Human genes 0.000 description 3
- 108010071390 Serum Albumin Proteins 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000003531 protein hydrolysate Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 229950010030 dl-alanine Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- CPQXCGMKIYKTNV-JKMUOGBPSA-N (3r,4s,5r)-n-acetyl-3,4,5,6-tetrahydroxyhexanamide Chemical compound CC(=O)NC(=O)C[C@@H](O)[C@H](O)[C@H](O)CO CPQXCGMKIYKTNV-JKMUOGBPSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241001391944 Commicarpus scandens Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-JFNONXLTSA-N L-mannopyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-JFNONXLTSA-N 0.000 description 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012792 lyophilization process Methods 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229940031960 pneumococcal polysaccharide vaccine Drugs 0.000 description 1
- 230000009979 protective mechanism Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/021,861 US4221906A (en) | 1979-03-19 | 1979-03-19 | Stabilization of pneumococcal polysaccharides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS55159799A JPS55159799A (en) | 1980-12-12 |
| JPH0236236B2 true JPH0236236B2 (Sortimente) | 1990-08-16 |
Family
ID=21806554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3046580A Granted JPS55159799A (en) | 1979-03-19 | 1980-03-12 | Purification of capsule forming polysaccharide |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4221906A (Sortimente) |
| EP (1) | EP0017322B1 (Sortimente) |
| JP (1) | JPS55159799A (Sortimente) |
| AR (1) | AR220822A1 (Sortimente) |
| AT (1) | ATE2114T1 (Sortimente) |
| CA (1) | CA1135643A (Sortimente) |
| DE (1) | DE3061466D1 (Sortimente) |
| ES (1) | ES489694A0 (Sortimente) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12508779B2 (en) | 2018-06-21 | 2025-12-30 | Tape Weaving Sweden Ab | Ultra-thin pre-preg sheets and composite materials thereof |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2510606A1 (fr) * | 1981-07-30 | 1983-02-04 | Berri Balzac | Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins |
| BE889979A (fr) * | 1981-08-14 | 1982-02-15 | Smith Kline Rit | Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation |
| US4542123A (en) * | 1982-01-11 | 1985-09-17 | Massachusetts Institute Of Technology | Composition and method for increasing brain tyrosine levels |
| US4600583A (en) * | 1982-09-07 | 1986-07-15 | Tetra Consultants Inc. | Pharmaceutical compositions |
| DE3601922A1 (de) * | 1986-01-23 | 1987-07-30 | Behringwerke Ag | Stabilisiertes virus-antigen, verfahren zu seiner herstellung und seine verwendung |
| FR2619122B1 (fr) * | 1987-08-03 | 1990-03-09 | Pasteur Institut | Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede |
| CA2059692C (en) * | 1991-01-28 | 2004-11-16 | Peter J. Kniskern | Pneumoccoccal polysaccharide conjugate vaccine |
| CA2059693C (en) * | 1991-01-28 | 2003-08-19 | Peter J. Kniskern | Polysaccharide antigens from streptococcus pneumoniae |
| KR101500771B1 (ko) | 2007-03-23 | 2015-03-18 | 와이어쓰 엘엘씨 | 스트렙토코커스 뉴모니아 협막 다당류를 제조하기 위한 단축 정제 방법 |
| PT2379734T (pt) * | 2008-12-18 | 2018-04-27 | Wyeth Llc | Método para o controlo da massa molecular do polissacárido do serotipo 19a de streptococcus pneumoniae |
| CN102257127B (zh) | 2008-12-18 | 2014-01-01 | 惠氏有限责任公司 | 使用二氧化碳控制肺炎链球菌多糖分子量的方法 |
| EP3436061A4 (en) | 2016-03-31 | 2019-12-04 | Liffey Biotech Limited | Saccharide-polypeptide-conjugate compositions and methods of use thereof |
| US12257295B2 (en) | 2017-10-04 | 2025-03-25 | Pogona, LLC | Saccharide-polypeptide conjugate compositions and methods of use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2528972A (en) * | 1947-05-15 | 1950-11-07 | Western Reserve University | Prophylactic toxoid compound and method of making same |
| US3436311A (en) * | 1966-02-28 | 1969-04-01 | Pillsbury Co | Fungal polysaccharide composition and method for making same |
| US4043952A (en) * | 1975-05-09 | 1977-08-23 | National Starch And Chemical Corporation | Surface treatment process for improving dispersibility of an absorbent composition, and product thereof |
| US4090919A (en) * | 1976-01-29 | 1978-05-23 | Tanabe Seiyaku Co., Ltd. | Water-insoluble tannin preparation for immobilization of proteins |
-
1979
- 1979-03-19 US US06/021,861 patent/US4221906A/en not_active Expired - Lifetime
-
1980
- 1980-01-17 CA CA000343904A patent/CA1135643A/en not_active Expired
- 1980-02-15 AT AT80300443T patent/ATE2114T1/de not_active IP Right Cessation
- 1980-02-15 DE DE8080300443T patent/DE3061466D1/de not_active Expired
- 1980-02-15 EP EP80300443A patent/EP0017322B1/en not_active Expired
- 1980-03-12 JP JP3046580A patent/JPS55159799A/ja active Granted
- 1980-03-12 AR AR280285A patent/AR220822A1/es active
- 1980-03-18 ES ES489694A patent/ES489694A0/es active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12508779B2 (en) | 2018-06-21 | 2025-12-30 | Tape Weaving Sweden Ab | Ultra-thin pre-preg sheets and composite materials thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| US4221906A (en) | 1980-09-09 |
| EP0017322A1 (en) | 1980-10-15 |
| AR220822A1 (es) | 1980-11-28 |
| EP0017322B1 (en) | 1982-12-29 |
| CA1135643A (en) | 1982-11-16 |
| ES8102805A1 (es) | 1981-02-16 |
| ES489694A0 (es) | 1981-02-16 |
| DE3061466D1 (en) | 1983-02-03 |
| ATE2114T1 (de) | 1983-01-15 |
| JPS55159799A (en) | 1980-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0236236B2 (Sortimente) | ||
| US4124576A (en) | Method of producing intravenously injectable gamma globulin | |
| EP0024493B1 (en) | Multivalent pneumococcal vaccine | |
| US4165370A (en) | Injectable gamma globulin | |
| FI61807B (fi) | Foerfarande foer stabilisering av meningokockpolysackarid | |
| CA1209473A (en) | Stable interferon b-composition and a method of stabilizing interferon b | |
| US20030143222A1 (en) | Method of producing igg | |
| JPS60193925A (ja) | 凍結乾燥製剤化ワクチン | |
| Felton et al. | Pneumococcal antigenic polysaccharide substances from animal tissues | |
| JPH10500955A (ja) | コポリマー１ | |
| JPH11505824A (ja) | ポリリボシルリビトールリン酸を含有するワクチン組成物およびその製造方法 | |
| JPH11507072A (ja) | ボツリヌス毒素またはボツリヌス神経毒の薬学的組成物および製造方法 | |
| JPH10500990A (ja) | 各種物質の再水和または融解時の凝集を防止する方法及び該方法により得られる組成物 | |
| EP0157899A2 (en) | Multivalent pneumococcal vaccine and preparation thereof | |
| JPS59225125A (ja) | 改良された静脈内投与可能な免疫性グロブリン組成物 | |
| Bavoil et al. | Physical interaction between the phage lambda receptor protein and the carrier-immobilized maltose-binding protein of Escherichia coli. | |
| US3637640A (en) | Orgotein stabilized with saccharide process and products | |
| JPH0351692B2 (Sortimente) | ||
| JPH0625069B2 (ja) | Ｂ型肝炎ワクチン製造方法 | |
| JPH0789951B2 (ja) | 遺伝子発現産物の精製法 | |
| EP0123375B1 (en) | Gamma-globulin preparation for intravenous administration | |
| TW202400801A (zh) | 用於克服治療性載體及蛋白質之免疫原性之耐受性免疫修飾奈米粒子 | |
| EP0954326B2 (en) | A process for viral inactivation of lyophilized blood proteins | |
| US3989818A (en) | Influenza virus vaccine | |
| JP2001055340A (ja) | アルブミン製剤の製造方法 |